论文部分内容阅读
目的 进一步验证中药新制剂强力升白片对白细胞下降患者的治疗作用。方法 选择因接受化疗而致白细胞下降的患者58例,随机分为治疗组和对照组,其中,治疗组33例,对照组28例。治疗组口服强力生白片,对照组服用利血生和鲨肝醇,对照观察2组疗效。结果 两组药物对分疗所致白细胞下降的患者,均有使之升高的作用,且其疗效之差异无统计学意义(P>0.05),但在临床症状改善方面,两组疗效之差,则有统计学意义(P<0.05)。结论 强力升白片对化疗所致的白细胞降低患者,确有升高其白细胞的作用,其疗效与利血生和鲨肝醇相近,但在改善患者临床症状方面,其疗效则优于前述西药。
Objective To further verify the therapeutic effect of a new Chinese medicine preparation, Lisheng Shengbai Tablets, on patients with leukopenia. Methods Fifty-eight patients with leukopenia due to chemotherapy were randomly divided into treatment group and control group, including 33 cases in treatment group and 28 cases in control group. The treatment group was given oral strength white tablets, the control group was treated with Lixuesheng and shark liver alcohol, and the curative effect of the two groups was observed. Results The effect of the two groups of drugs on the leukopenia caused by treatment was increased, and there was no significant difference in the efficacy (P>0.05). However, in the improvement of clinical symptoms, the efficacy of the two groups was poor. Statistically significant (P<0.05). Conclusion Qianglishengbai Tablets can effectively increase the leukocytes in patients with chemotherapy-induced leukopenia. Its efficacy is similar to that of Lixuesheng and Shaheganol, but its efficacy is better than the aforementioned Western medicine in improving the clinical symptoms of patients. .